Home | 2022 Spotlight

top of page

What This Means
CEO Connect
KOL Connect
Contact Us
- Disclaimer
- Privacy Policy
Email Alerts
More

Use tab to navigate through the menu items.

Featuring

Jeffrey F. Eisenberg

Chief Executive Officer

Tuesday 10.24, 1:00PM ET

J Eisenberg-0866A1_edited.jpg

Submit Your Questions Here!

First name

Last name

Email

Company

Type your questions

Thanks for submitting!

JTC Team and Virtual Investor Co. are paid consultants to Adolore Biotherapeutics, Inc; Aeterna Zentaris, Inc; AIM ImmunoTech, Inc; American Resources Corporation; Autonomix Medical Inc.; Ceapro, Inc; CNS Pharmaceuticals, Inc; enVVeno Medical Corporation; Exxel Pharma, Inc; GRI Bio, Inc; iTolerance, Inc; Kaida BioPharma, Inc; Moleculin Biotech, Inc; Outlook Therapeutics, Inc.; Palisade Bio; Sonnet BioTherapeutics, Inc.; TuHura Biosciences, Inc.; and Xenetic Biosciences, Inc. JTC Team and Virtual Investor Co. are investor relations and corporate communications firms. Any content included on this website shall not be construed as an offer to purchase securities of the applicable companies. Interested parties are responsible for conducting their own due diligence and are encouraged to review the companies’ websites and the SEC website for the latest information and filings on each company.

CONTACT US

SIGN UP FOR EMAIL ALERTS

© 2024 by JTC Team, LLC. All rights reserved.

Privacy Policy

info@virtualinvestorco.com

Full Name*

Enter Your Email

Thanks for submitting!

bottom of page